The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
Abstract
BACKGROUND: The National Institutes of Health Office of Medical Applications of Research commissioned a structured literature review on the incidence, treatment, and outcomes of ductal carcinoma in situ (DCIS) as a background article for the State of the Science Conference on Diagnosis and Management of DCIS. METHODS: Published studies were identified and abstracted from MEDLINE and other sources. We include articles published between 1965 and January 31, 2009; 374 publications were identified that addressed DCIS incidence, staging, treatment, and outcomes in adult women. RESULTS: In the United States, DCIS incidence rose from 1.87 per 100 000 in 1973-1975 to 32.5 in 2004. Incidence increased in all ages but more so in women older than 50 years. Increased use of mammography explains some but not all of the increased incidence. Risk factors for incident DCIS include older age and family history. Although tamoxifen treatment prevented both invasive breast cancer and DCIS, raloxifene treatment decreased incidence of invasive breast cancer but not DCIS. Among patients with DCIS, magnetic resonance imaging was more sensitive than mammography for detecting multicentric disease and estimating tumor size. Because about 15% of patients with DCIS identified on core needle biopsy are diagnosed with invasive breast cancer after excision or mastectomy, the accuracy of sentinel lymph node biopsy after excision is relevant to surgical management of DCIS. Most studies demonstrated that sentinel lymph node biopsy is feasible after breast-conserving surgery (BCS). Younger age, positive surgical margins, tumor size and grade, and comedo necrosis were consistently related to DCIS recurrence. DCIS outcomes after either mastectomy or BCS plus radiation therapy were superior to BCS alone. Tamoxifen treatment after DCIS diagnosis reduced risk of recurrent disease. CONCLUSIONS: Scientific questions deserving further investigation include the relationship between mammography use and DCIS incidence and whether imaging technologies and treatment guidelines can be modified to focus on lesions that are most likely to become clinically problematic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer
Lehman, C. D., Gatsonis, C., Kuhl, C. K., Hendrick, R. E., Pisano, E. D., Hanna, L., Peacock, S., Smazal, S. F., Maki, D. D., Julian, T. B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065447 · Cited by 945
Fisher, B., Costantino, J., Redmond, C., Fisher, E., Margolese, R., Dimitrov, N., Wolmark, N., Wickerham, D. L., Deutsch, M., Ore, L., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282201 · Cited by 827
Clarke, M. J., Collins, R., Davies, C., Godwin, J., Gray, R. G., & Peto, R. (2000) · The Lancet · Cited by 824
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09962-2 · Cited by 747
Martino, S., Cauley, J. A., Barrett-Connor, E., Powles, T. J., Mershon, J., Disch, D., Secrest, R. J., Cummings, S. R., & For the CORE Investigators (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh319 · Cited by 684
The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast
Silverstein, M. J., Lagios, M. D., Groshen, S., Waisman, J. R., Lewinsky, B. S., Martino, S., Gamagami, P., & Colburn, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401902 · Cited by 673
Bijker, N., Meijnen, P., Peterse, J. L., Bogaerts, J., Van Hoorebeeck, I., Julien, J.-P., Gennaro, M., Rouanet, P., Avril, A., Fentiman, I. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1366 · Cited by 663
Houghton, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13859-7 · Cited by 599
Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography
Ernster, V. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1546 · Cited by 582
Cuzick, J., Forbes, J. F., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., & Howell, A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk049 · Cited by 534
FISHER, B. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90133-2 · Cited by 516
Miller, A. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1490 · Cited by 512
Fisher, E. R., Dignam, J., Tan-Chiu, E., Costantino, J., Fisher, B., Paik, S., Wolmark, N., & for the National Surgical Adjuvant Breast Bowel Project (NSABP) Collaborating Investigators (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990801)86:3<429::aid-cncr11>3.0.co;2-y · Cited by 500
Bijker, N., Peterse, J. L., Duchateau, L., Julien, J.-P., Fentiman, I. S., Duval, C., Di Palma, S., Simony-Lafontaine, J., de Mascarel, I., & van de Vijver, M. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2263 · Cited by 496
Warner, E., Plewes, D. B., Shumak, R. S., Catzavelos, G. C., Di Prospero, L. S., Yaffe, M. J., Goel, V., Ramsay, E., Chart, P. L., Cole, D. E. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3524 · Cited by 461
THE SWEDISH TWO-COUNTY TRIAL TWENTY YEARS LATER
Tabár, L., Vitak, B., Chen, H.-H., Duffy, S. W., Yen, M.-F., Chiang, C.-F., Krusemo, U. B., Tot, T., & Smith, R. A. (2000) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(05)70191-3 · Cited by 460
Powles, T. J., Ashley, S., Tidy, A., Smith, I. E., & Dowsett, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk050 · Cited by 430
Miller, A. B., To, T., Baines, C. J., & Wall, C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00005 · Cited by 394
The Gothenburg Breast Screening Trial
Bjurstam, N., Björneld, L., Warwick, J., Sala, E., Duffy, S. W., Nyström, L., Walker, N., Cahlin, E., Eriksson, O., Hafström, L., et al. (2003) · Cancer · doi:10.1002/cncr.11361 · Cited by 308
Essentials of Epidemiology in Public Health
Aschengrau, A., & Seage, G. R. (2013) · Cited by 307
Ernster, V. L., Barclay, J., Kerlikowske, K., Wilkie, H., & Ballard-Barbash, R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.953 · Cited by 298
Reeves, G. K., Beral, V., Green, J., Gathani, T., & Bull, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70911-1 · Cited by 284
Recent Trends in Breast Cancer Among Younger Women in the United States
Brinton, L. A., Sherman, M. E., Carreon, J. D., & Anderson, W. F. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn344 · Cited by 267
Periodic Screening for Breast Cancer: The HIP Randomized Controlled Trial
Shapiro, S. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.27 · Cited by 257
Holmberg, L., Garmo, H., Granstrand, B., Ringberg, A., Arnesson, L.-G., Sandelin, K., Karlsson, P., Anderson, H., & Emdin, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7969 · Cited by 255
Bruening, W., Fontanarosa, J., Tipton, K., Treadwell, J. R., Launders, J., & Schoelles, K. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-1-201001050-00190 · Cited by 251
Kerlikowske, K. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg097 · Cited by 243
Veronesi, U., Maisonneuve, P., Rotmensz, N., Bonanni, B., Boyle, P., Viale, G., Costa, A., Sacchini, V., Travaglini, R., D'Aiuto, G., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk154 · Cited by 242
Gapstur, S. M., Morrow, M., & Sellers, T. A. (1999) · JAMA · doi:10.1001/jama.281.22.2091 · Cited by 231
Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial
Frisell, J., Lidbrink, E., Hellström, L., & Rutqvist, L.-E. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005872617944 · Cited by 223
Li, C. I., Malone, K. E., Saltzman, B. S., et al. (2006) · Cancer · doi:10.1002/cncr.21864 · Cited by 190
Partridge, A., Adloff, K., Blood, E., Dees, E. C., Kaelin, C., Golshan, M., Ligibel, J., de Moor, J. S., Weeks, J., Emmons, K., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn010 · Cited by 176
Rakovitch, E., Franssen, E., Kim, J., Ackerman, I., Pignol, J.-P., Paszat, L., Pritchard, K. I., Ho, C., & Redelmeier, D. A. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021853302033 · Cited by 171
Absence of HER4 Expression Predicts Recurrence of Ductal Carcinoma In situ of the Breast
Barnes, N. L. P., Khavari, S., Boland, G. P., Cramer, A., Knox, W. F., & Bundred, N. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1633 · Cited by 154
Kerlikowske, K. M., Miglioretti, D. L., Ballard-Barbash, R. R., Weaver, D. L., Buist, D. S. M., Barlow, W. E., Cutter, G., Geller, B. M., Yankaskas, B. C., Taplin, S. H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.151 · Cited by 129
Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson, T., Anderson, K. E., Lazovich, D., & Folsom, A. R. (2002) · PubMed · Cited by 118
Corson, S. L. (2006) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2006.06.015 · Cited by 112
Viehweg, P., Lampe, D., Buchmann, J., & Heywang-Köbrunner, S. H. (2000) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/bf02678476 · Cited by 95
The Edinburgh randomised trial of screening for breast cancer: Description of method
Roberts, M. M., Alexander, F. E., Anderson, T. J., Forrest, A. P. M., Hepburn, W., Huggins, A., Kirkpatrick, A. E., Lamb, J., Lutz, W., & Muir, B. B. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.132 · Cited by 93
Risk factors for carcinoma in situ of the breast.
Trentham‐Dietz, A., Newcomb, P. A., Storer, B. E., & Remington, P. L. (2000) · PubMed · Cited by 93
Meijnen, P., Oldenburg, H. S. A., Peterse, J. L., Bartelink, H. G. M. M., & Rutgers, E. J. T. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9659-2 · Cited by 87
Hartman, A., Daniel, B. L., Kurian, A. W., Mills, M. A., Nowels, K. W., Dirbas, F. M., Kingham, K. E., Chun, N., Herfkens, R. J., Ford, J. M., et al. (2004) · Cancer · doi:10.1002/cncr.11926 · Cited by 78
Effectiveness of Radiation Therapy in Older Women With Ductal Carcinoma In Situ
Smith, B. D., Haffty, B. G., Buchholz, T. A., Smith, G. L., Galusha, D. H., Bekelman, J. E., & Gross, C. P. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj359 · Cited by 78
Meijnen, P., Oldenburg, H. S. A., Loo, C. E., Nieweg, O. E., Peterse, J. L., & Rutgers, E. J. T. (2007) · British journal of surgery · doi:10.1002/bjs.5735 · Cited by 77
van der Velden, A. P. S., van Vugt, R., van Dijck, J. A. A. M., Leer, J. W. H., & Wobbes, T. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.062 · Cited by 57
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Lyman, G. H., Temin, S., Edge, S. B., Newman, L. A., Turner, R. R., Weaver, D. L., Benson, A. B., Bosserman, L. D., Burstein, H. J., Cody, H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.1177 · Cited by 1,026
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0030 · Cited by 951
An evolutionary perspective on field cancerization
Curtius, K., Wright, N. A., & Graham, T. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.102 · Cited by 509
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing
Casasent, A. K., Schalck, A., Gao, R., Sei, E., Long, A., Pangburn, W., Casasent, T., Meric-Bernstam, F., Edgerton, M. E., & Navin, N. E. (2018) · Cell · doi:10.1016/j.cell.2017.12.007 · Cited by 411
Metadata
- Authors
- Virnig, B. A., Tuttle, T. M., Shamliyan, T., & Kane, R. L.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01-13
- Volume
- 102
- Issue
- 3
- Pages
- 170-178
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2126212561
- Cited by
- 608
- References
- 50
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.